DTC Smartphone Ads Present An “Interesting” Problem For DDMAC
Add another electronic advertising vehicle to DDMAC’s growing list of potentially problematic DTC media that it must regulate: mobile device promotion.
You may also be interested in...
Both tablets and huge TVs have proliferated since the last research of the impact of superimposed text.
The first warning letter of the year from FDA’s Office of Prescription Drug Promotion goes to Teva for web pages and materials displayed at a medical conference that overstated the safety and efficacy of its MS drug Copaxone.
As drug makers seek ways to reduce the cost of clinical trials, Pfizer thinks the solution could be asking patients to reach into their own pockets – for their cell phones.